Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

NCT00607997

Conditions
Acute Disease, Acute Myeloid Leukemia, Bone Marrow Diseases, +12 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Rocky Mountain Blood and Marrow Transplant Program Denver, Colorado, United States
View all 20 locations
View Trial Details
Completed

A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms

NCT01309789

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma

NCT00866047

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 22 locations
View Trial Details
Completed

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

NCT00848926

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 27 locations
View Trial Details

Related conditions